Update on the hyper immunoglobulin M syndromes

Abstract

Summary The Hyper‐immunoglobulin M syndromes (HIGM) are a heterogeneous group of genetic disorders resulting in defects of immunoglobulin class switch recombination (CSR), with or without defects of somatic hypermutation (SHM). They can be classified as defects of signalling through CD40 causing both a humoral immunodeficiency and a susceptibility to opportunistic infections, or intrinsic defects in B cells of the mechanism of CSR resulting in a pure humoral immunodeficiency. A HIGM picture can also be seen as part of generalized defects of DNA repair and in antibody deficiency syndromes, such as common variable immunodeficiency. CD40 signalling defects may require corrective therapy with bone marrow transplantation. Gene therapy, a potential curative approach in the future, currently remains a distant prospect. Those with a defective CSR mechanism generally do well on immunologoblulin replacement therapy. Complications may include autoimmunity, lymphoid hyperplasia and, in some cases, a predisposition to lymphoid malignancy.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 103

1. 1.

   Agematsu K, Nagumo H, Shinozaki K, Hokibara S, Yasui K, Terada K, Kawamura N, Toba T, Nonoyama S, Ochs HD, Komiyama A. Absence of IgD-CD27(+) memory B cell population in X-linked hyper-IgM syndrome. The Journal of Clinical Investigation. 1998;102:853-860.

   Not in our library10.1172/jci3409

2. 2.

   Atkinson TP, Smith CA, Hsu YM, Garber E, Su L, Howard TH, Prchal JT, Everson MP, Cooper MD. Leukocyte transfusion-associated granulocyte responses in a patient with X-linked hyper-IgM syndrome. Journal of Clinical Immunology. 1998;18:430-439.

   Not in our library10.1023/a:1023286807853

3. 3.

   Banatvala N, Davies J, Kanariou M, Strobel S, Levinsky R, Morgan G. Hypogammaglobulinaemia associated with normal or increased IgM (the hyper IgM syndrome): a case series review. Archives of Disease in Childhood. 1994;71:150-152.

   Not in our library10.1136/adc.71.2.150

4. 4.

   Benesch M, Pfleger A, Eber E, Orth U, Zach MS. Disseminated cytomegalovirus infection as initial manifestation of hyper-IgM syndrome in a 15-month-old boy. European Journal of Pediatrics. 2000;159:453-455.

   Not in our library10.1007/s004310051306

5. 5.

   Bransteitter R, Pham P, Scharff MD, Goodman MF. Activation-induced cytidine deaminase deaminates deoxycytidine on single-stranded DNA but requires the action of RNase. Proceedings of the National Academy of Sciences of the United States of America. 2003;100:4102-4107.

   Not in our library10.1073/pnas.0730835100

6. 6.

   Brown MP, Topham DJ, Sangster MY, Zhao J, Flynn KJ, Surman SL, Woodland DL, Doherty PC, Farr AG, Pattengale PK, Brenner MK. Thymic lymphoproliferative disease after successful correction of CD40 ligand deficiency by gene transfer in mice. Nature Medicine. 1998;4:1253-1260.

   Not in our library10.1038/3233

7. 7.

   Bucher HC, Griffith L, Guyatt GH, Opravil M. Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1997;15:104-114.

   Not in our library10.1097/00042560-199706010-00002

8. 8.

   Chapel HM, Spickett GP, Ericson D, Engl W, Eibl MM, Bjorkander J. The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy. Journal of Clinical Immunology. 2000;20:94-100.

   Not in our library10.1023/a:1006678312925

9. 9.

   Coffman RL, Lebman DA, Rothman P. Mechanism and regulation of immunoglobulin isotype switching. Advances in Immunology. 1993;54:229-270.

   Not in our library10.1016/s0065-2776(08)60536-2

10. 10.

    Courtois G, Smahi A, Reichenbach J, Doffinger R, Cancrini C, Bonnet M, Puel A, Chable-Bessia C, Yamaoka S, Feinberg J, Dupuis-Girod S, Bodemer C, Livadiotti S, Novelli F, Rossi P, Fischer A, Israel A, Munnich A, Le Diest F, Casanova JL. A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency. The Journal of Clinical Investigation. 2003;112:1108-1115.

    Not in our library10.1172/jci18714

11. 11.

    Dai YS, Liang MG, Gellis SE, Bonilla FA, Schneider LC, Geha RS, Orange JS. Characteristics of mycobacterial infection in patients with immunodeficiency and nuclear factor-kappaB essential modulator mutation, with or without ectodermal dysplasia. Journal of the American Academy of Dermatology. 2004;51:718-722.

    Not in our library10.1016/j.jaad.2004.05.032

12. 12.

    DeKruyff RH, Gieni RS, Umetsu DT. Antigen-driven but not lipopolysaccharide-driven IL-12 production in macrophages requires triggering of CD40. Journal of Immunology. 1997;158:359-366.

    Not in our library

13. 13.

    Delia D, Piane M, Buscemi G, Savio C, Palmeri S, Lulli P, Carlessi L, Fontanella E, Chessa L. MRE11 mutations and impaired ATM-dependent responses in an Italian family with ataxia-telangiectasia-like disorder. Human Molecular Genetics. 2004;13:2155-2163.

    Not in our library10.1093/hmg/ddh221

14. 14.

    Dimicoli S, Bensoussan D, Latger-Cannard V, Straczek J, Antunes L, Mainard L, Dao A, Barbe F, Araujo C, Clement L, Feugier P, Lecompte T, Stoltz JF, Bordigoni P. Complete recovery from Cryptosporidium parvum infection with gastroenteritis and sclerosing cholangitis after successful bone marrow transplantation in two brothers with X-linked hyper-IgM syndrome. Bone Marrow Transplantation. 2003;32:733-737.

    Not in our library10.1038/sj.bmt.1704211

15. 15.

    Doffinger R, Smahi A, Bessia C, Geissmann F, Feinberg J, Durandy A, Bodemer C, Kenwrick S, Dupuis-Girod S, Blanche S, Wood P, Rabia SH, Headon DJ, Overbeek PA, Le DF, Holland SM, Belani K, Kumararatne DS, Fischer A, Shapiro R, Conley ME, Reimund E, Kalhoff H, Abinun M, Munnich A, Israel A, Courtois G, Casanova JL. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nature Genetics. 2001;27:277-285.

    Not in our library10.1038/85837

16. 16.

    Dupuis-Girod S, Cancrini C, Le DF, Palma P, Bodemer C, Puel A, Livadiotti S, Picard C, Bossuyt X, Rossi P, Fischer A, Casanova JL. Successful allogeneic hemopoietic stem cell transplantation in a child who had anhidrotic ectodermal dysplasia with immunodeficiency. Pediatrics. 2006;118:e205-e211.

    Not in our library10.1542/peds.2005-2661

17. 17.

    Durandy A. Immunoglobulin class switch recombination: study through human natural mutants. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 2009;364:577-582.

    Not in our library10.1098/rstb.2008.0210

18. 18.

    Durandy A, Peron S, Fischer A. Hyper-IgM syndromes. Current Opinion in Rheumatology. 2006;18:369-376.

    Not in our library10.1097/01.bor.0000231905.12172.b5

19. 19.

    Engel D, Seijkens T, Poggi M, Sanati M, Thevissen L, Beckers L, Wijnands E, Lievens D, Lutgens E. The immunobiology of CD154-CD40-TRAF interactions in atherosclerosis. Seminars in Immunology. 2009;21:308-312.

    Not in our library10.1016/j.smim.2009.06.004

20. 20.

    Etzioni A, Ben-Barak A, Peron S, Durandy A. Ataxia-telangiectasia in twins presenting as autosomal recessive hyper-immunoglobulin M syndrome. The Israel Medical Association Journal. 2007;9:406-407.

    Not in our library

21. 21.

    Fagarasan S, Muramatsu M, Suzuki K, Nagaoka H, Hiai H, Honjo T. Critical roles of activation-induced cytidine deaminase in the homeostasis of gut flora. Science. 2002;298:1424-1427.

    Not in our library10.1126/science.1077336

22. 22.

    Fernet M, Gribaa M, Salih MA, Seidahmed MZ, Hall J, Koenig M. Identification and functional consequences of a novel MRE11 mutation affecting 10 Saudi Arabian patients with the ataxia telangiectasia-like disorder. Human Molecular Genetics. 2005;14:307-318.

    Not in our library10.1093/hmg/ddi027

23. 23.

    Ferrari S, Giliani S, Insalaco A, Al-Ghonaium A, Soresina AR, Loubser M, Avanzini MA, Marconi M, Badolato R, Ugazio AG, Levy Y, Catalan N, Durandy A, Tbakhi A, Notarangelo LD, Plebani A. Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proceedings of the National Academy of Sciences of the United States of America. 2001;98:12614-12619.

    Not in our library10.1073/pnas.221456898

24. 24.

    Fish JD, Duerst RE, Gelfand EW, Orange JS, Bunin N. Challenges in the use of allogeneic hematopoietic SCT for ectodermal dysplasia with immune deficiency. Bone Marrow Transplantation. 2009;43:217-221.

    Not in our library10.1038/bmt.2008.308

25. 25.

    Gennery AR, Khawaja K, Veys P, Bredius RG, Notarangelo LD, Mazzolari E, Fischer A, Landais P, Cavazzana-Calvo M, Friedrich W, Fasth A, Wulffraat NM, Matthes-Martin S, Bensoussan D, Bordigoni P, Lange A, Pagliuca A, Andolina M, Cant AJ, Davies EG. Treatment of CD40 ligand deficiency by hematopoietic stem cell transplantation: a survey of the European experience, 1993–2002. Blood. 2004;103:1152-1157.

    Not in our library10.1182/blood-2003-06-2014

26. 26.

    Ghia P, ten BE, Rolink AG, Melchers F. B-cell development: a comparison between mouse and man. Immunology Today. 1998;19:480-485.

    Not in our library10.1016/s0167-5699(98)01330-9

27. 27.

    Gilmour KC, Walshe D, Heath S, Monaghan G, Loughlin S, Lester T, Norbury G, Cale CM. Immunological and genetic analysis of 65 patients with a clinical suspicion of X linked hyper-IgM. Molecular Pathology. 2003;56:256-262.

    Not in our library10.1136/mp.56.5.256

28. 28.

    Giovannetti A, Mazzetta F, Caprini E, Aiuti A, Marziali M, Pierdominici M, Cossarizza A, Chessa L, Scala E, Quinti I, Russo G, Fiorilli M. Skewed T-cell receptor repertoire, decreased thymic output, and predominance of terminally differentiated T cells in ataxia telangiectasia. Blood. 2002;100:4082-4089.

    Not in our library10.1182/blood-2002-03-0976

29. 29.

    Gologan A, Sepulveda AR. Microsatellite instability and DNA mismatch repair deficiency testing in hereditary and sporadic gastrointestinal cancers. Clinics in Laboratory Medicine. 2005;25:179-196.

    Not in our library10.1016/j.cll.2004.12.001

30. 30.

    Hadzic N, Pagliuca A, Rela M, Portmann B, Jones A, Veys P, Heaton ND, Mufti GJ, Mieli-Vergani G. Correction of the hyper-IgM syndrome after liver and bone marrow transplantation. The New England Journal of Medicine. 2000;342:320-324.

    Not in our library10.1056/nejm200002033420504

31. 31.

    Hase K, Takahashi D, Ebisawa M, Kawano S, Itoh K, Ohno H. Activation-induced cytidine deaminase deficiency causes organ-specific autoimmune disease. PLoS ONE. 2008;3:e3033.

    Not in our library10.1371/journal.pone.0003033

32. 32.

    Hayashi T, Rao SP, Meylan PR, Kornbluth RS, Catanzaro A. Role of CD40 ligand in Mycobacterium avium infection. Infection and Immunity. 1999;67:3558-3565.

    Not in our library10.1128/iai.67.7.3558-3565.1999

33. 33.

    Hayward AR, Levy J, Facchetti F, Notarangelo L, Ochs HD, Etzioni A, Bonnefoy JY, Cosyns M, Weinberg A. Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. Journal of Immunology. 1997;158:977-983.

    Not in our library

34. 34.

    Herve M, Isnardi I, Ng YS, Bussel JB, Ochs HD, Cunningham-Rundles C, Meffre E. CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance. The Journal of Experimental Medicine. 2007;204:1583-1593.

    Not in our library10.1084/jem.20062287

35. 35.

    Imai K, Slupphaug G, Lee WI, Revy P, Nonoyama S, Catalan N, Yel L, Forveille M, Kavli B, Krokan HE, Ochs HD, Fischer A, Durandy A. Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nature Immunology. 2003a;4:1023-1028.

    Not in our library10.1038/ni974

36. 36.

    Imai K, Catalan N, Plebani A, Marodi L, Sanal O, Kumaki S, Nagendran V, Wood P, Glastre C, Sarrot-Reynauld F, Hermine O, Forveille M, Revy P, Fischer A, Durandy A. Hyper-IgM syndrome type 4 with a B lymphocyte-intrinsic selective deficiency in Ig class-switch recombination. The Journal of Clinical Investigation. 2003b;112:136-142.

    Not in our library10.1172/jci18161

37. 37.

    Imai K, Zhu Y, Revy P, Morio T, Mizutani S, Fischer A, Nonoyama S, Durandy A. Analysis of class switch recombination and somatic hypermutation in patients affected with autosomal dominant hyper-IgM syndrome type 2. Clinical Immunology. 2005;115:277-285.

    Not in our library10.1016/j.clim.2005.02.003

38. 38.

    Imai K, Shimadzu M, Kubota T, Morio T, Matsunaga T, Park YD, Yoshioka A, Nonoyama S. Female hyper IgM syndrome type 1 with a chromosomal translocation disrupting CD40LG. Biochimica et Biophysica Acta. 2006;1762:335-340.

    Not in our library10.1016/j.bbadis.2005.10.003

39. 39.

    Inwald DP, McDowall A, Peters MJ, Callard RE, Klein NJ. CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Circulation Research. 2003;92:1041-1048.

    Not in our library10.1161/01.res.0000070111.98158.6c

40. 40.

    Jain A, Ma CA, Liu S, Brown M, Cohen J, Strober W. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nature Immunology. 2001;2:223-228.

    Not in our library10.1038/85277

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.